Abstract #: WEAA0104

12
Probiotic and IL-21 Treatment Promotes Th17 Cell Recovery in ARV- Treatment of Pigtail Macaques Alexandra M. Ortiz Laboratory of Jason Brenchley July 23, 2014 Abstract #: WEAA0104

description

Abstract #: WEAA0104. Probiotic and IL-21 Treatment Promotes Th17 Cell Recovery in ARV-Treatment of Pigtail Macaques Alexandra M. Ortiz Laboratory of Jason Brenchley July 23, 2014. Th17 Cells and Probiotics in HIV-associated Intestinal Immune Dysfunction. - PowerPoint PPT Presentation

Transcript of Abstract #: WEAA0104

Page 1: Abstract #: WEAA0104

Probiotic and IL-21 Treatment Promotes Th17 Cell Recovery in ARV-Treatment of

Pigtail Macaques

Alexandra M. OrtizLaboratory of Jason Brenchley

July 23, 2014

Abstract #: WEAA0104

Page 2: Abstract #: WEAA0104

Th17 Cells and Probiotics in HIV-associated Intestinal Immune Dysfunction

• HIV is characterized by persistent GI immune dysfunction.• Preferential Th17 loss

• Th17 are antimicrobial CD4+ T-cells essential for intestinal immunity.• Generated in the context of commensal signaling

• Immune dysfunction correlates with microbial translocation and dysbiosis

• Probiotic supplementation of chronically-infected, ARV-treated macaques:• Increased colonic CD4+ T-cell function and frequency• Increased function but not frequency of colonic Th17 cells

• IL21 therapy in acutely SIV-infected macaques promotes Th17 retention during treatment (Pallikkuth PLoSPathog 2013)

(Klatt JCI 2013)

Page 3: Abstract #: WEAA0104

Experimental Design

• Animals: 11 Pigtail Macaques (Maccaca nemestrina)

• 6 animals treated with ARV + Probiotics (Pb) + IL-21, 5 ARV-only controls

• Infection: 3000 TCID50, SIVmac239 i.v.

• ARVs: 20-30 mg/kg PMPA i.v., 30mg/kg FTC i.v., 240 mg L’812 – daily

• Probiotics: 1011 live bacteria (VSL#3) oral - daily

• Bifidobacterium: breve, longum and infantis

• Lactobacillus: acidophilus, plantarum, paracasei, bulgaricus

• Streptococcus thermophilus

• IL-21: 50 ug/kg IL-21, s.c. – 5 weekly doses, early and late chronic

• RM IL-21 fused to RM IgG2 Fc, produced in S-2 cells

Page 4: Abstract #: WEAA0104

IL-21 and Probiotic Therapy do not Interfere with Viral Suppression

Vir

al Lo

ad (

log c

opie

s/m

L)

Day (relative to infection)

PTA2P031

Treatment initiation

(late) IL21(early) IL21

Page 5: Abstract #: WEAA0104

IL-21and Probiotic Therapy Improve Intestinal CD4+ T-Cell Frequency

Jejunum Rectal Biopsy

Day (relative to infection)

Perc

en

t C

D4

+ o

fC

D3

+ T

-cells

ARV onlyARV+Pb+IL21

PTA2P031

PTA2P031

Page 6: Abstract #: WEAA0104

IL-21and Probiotic Therapy do not Induce CD4+ T-cell Activation

PBMC LN

BAL Jej RB

Day (relative to infection)

Perc

en

t K

i67

+ o

f C

D4

+

TM

ARV onlyARV+Pb+IL21

Page 7: Abstract #: WEAA0104

IL-21and Probiotic Therapy Improve Intestinal Th17 Frequency

Perc

en

t IL

17

+ o

fm

em

ory

CD

4+

T-C

ells

Day (relative to infection)

Jejunum Rectal Biopsy

ARV onlyARV+Pb+IL21

Page 8: Abstract #: WEAA0104

IL-21and Probiotic Therapy Improve Polyfunctional Th17 Recovery

Perc

en

t Po

lyfu

nct

ion

al of

CD

3+

T-C

ells

Day (relative to infection)

Jejunum Rectal Biopsy

ARV onlyARV+Pb+IL21

Page 9: Abstract #: WEAA0104

IL-21 and Probiotic Therapy Moderately Reduced Colonic IDO Expression

ARV onlyARV+Pb+IL21

Perc

en

t ID

O+

Tis

sue

Colon Mesenteric LN

Page 10: Abstract #: WEAA0104

IL-21and Probiotic Therapy Reduce Comorbidities

Perc

ent

Inci

den

ce-F

ree A

nim

als

Day (relative to infection)

Page 11: Abstract #: WEAA0104

Conclusions and Future Directions

• Therapeutic treatment with probiotics and IL21 improved disease progression in ARV-treated macaques as measured by:– Intestinal CD4+ T-cell recovery– Improved intestinal Th17 frequency and functionality– Decreased incidence of health complications

• By what mechanism are Th17 cells expanded?• Would treatment promote enhanced protection against

microbial challenge?• Does probiotic and IL21 treatment reduce microbial

translocation and dysbiosis?

Page 12: Abstract #: WEAA0104

Acknowledgements

Brenchley Lab• Jason Brenchley• Nina Calantone• Kirby Carmack• Sarah DiNapoli• Zachary Klase• Molly Perkins• Carol Vinton

Veterinary StaffHeather CroniseRichard HerbertJoanna Swerczek

LMM Core

NCI-NIH• Jake Estes

Emory University – IL21• Mirko Paiardini• Francois Villinger

Gilead – PMPA/FTC• Michael Miller

Merck – L’812• Daria Hazuda

Sigma-Tau – VSL#3• Claudio De Simone